Study of ganaxolone in patients with Satus Epilepticus

Trial Profile

Study of ganaxolone in patients with Satus Epilepticus

Planning
Phase of Trial: Phase II

Latest Information Update: 01 Aug 2017

At a glance

  • Drugs Ganaxolone (Primary)
  • Indications Status epilepticus
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 01 Aug 2017 According to a Marinus Pharmaceuticals media release, the company anticipates to initiate this trial later in the year 2017.
    • 13 Mar 2017 According to Marinus Pharmaceuticals media release, company plans to initiate this trial in the second half of 2017
    • 05 Jan 2017 According to Marinus Pharmaceuticals media release, company plans to initiate this trial in the first half of 2017 and expects to announce data in the second half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top